Company Ensol Biosciences Inc.

Equities

A140610

KR7140610007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
4,000 ^KRW	-0.12%		-6.54%	-35.69%

2023	Ensol Biosciences Inc. announced that it has received KRW 4.99999995 billion in funding from Humedix Co., Ltd.	CI
2023	Ensol Biosciences Inc. announced that it expects to receive KRW 4.99999995 billion in funding from Humedix Co., Ltd.	CI

Ensol Biosciences Inc. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the development and sale of drugs for degenerative disc disease (DDD), osteoarthritis, triple negative breast cancer (TNBC), Alzheimer's disease (AD) and type I diabetes. In addition, it also produces and sells drugs for animal and provides bio big data analysis services. The drugs for Animal include drugs for animal osteoarthritis, as well as animal anticancer, among others. The bio big data analysis services are provided by knowledge-based in silico drug discovery (KISDD) platform and Ensol trans-omics network system (ETONS).

KRW in Million	2022	Weight	2023	Weight	Delta
Medicine 100.0 %	860	100.0 %	177	100.0 %	-79.46%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	860	100.0 %	177	100.0 %	-79.46%

Managers	Title	Age	Since
Hae-Jin Kim FOU	Founder	64	01-02-19
Eun-Jung Moon CTO	Chief Tech/Sci/R&D Officer	54	-
Nam-Deuk Jeon BRD	Director/Board Member	59	-
Tae-Oh Lee BRD	Director/Board Member	67	-
Tae-Geun Kim AUD	Comptroller/Controller/Auditor	62	22-03-28

Members of the board	Title	Age	Since
Tae-Oh Lee BRD	Director/Board Member	67	-
Hae-Jin Kim FOU	Founder	64	01-02-19
Eun-Jung Moon CTO	Chief Tech/Sci/R&D Officer	54	-
Nam-Deuk Jeon BRD	Director/Board Member	59	-
Byung-Chul Lee BRD	Director/Board Member	60	-
Jae-Hak Shim BRD	Director/Board Member	52	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,827,840	7,898,648 ( 72.95 %)	0	72.95 %
Stock B	0	467,566	0	0

Name	Equities	%	Valuation
HUMEDIX CO., LTD. 5.080 %	550,055	5.080 %	2 M ₩
Jae-wan Lee 4.265 %	461,858	4.265 %	2 M ₩

Ensol Biosciences, Inc.

51 Techno 10-ro Yuseong-gu

34036, Daejeon

http://www.ensolbio.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
ENSOL BIOSCIENCES INC.	-35.69%	25.34M
VERTEX PHARMACEUTICALS INCORPORATED	+9.58%	115B
REGENERON PHARMACEUTICALS, INC.	+12.41%	107B
ARGENX SE	-3.29%	21.6B
BIONTECH SE	-12.38%	22.31B
GENMAB A/S	-6.36%	19.19B
BEIGENE, LTD.	-3.35%	18.23B
WUXI APPTEC CO., LTD.	-38.57%	17.62B
NEUROCRINE BIOSCIENCES, INC.	+7.51%	14.26B
SAREPTA THERAPEUTICS, INC.	+35.67%	12.37B

Bio Therapeutic Drugs